David R. Staskin
Director/Board Member at Inpellis, Inc.
David R. Staskin active positions
| Companies | Position | Start | End |
|---|---|---|---|
Inpellis, Inc.
 Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | Director/Board Member | 2014-12-31 | - |
| Corporate Secretary | 2014-12-31 | - |
Career history of David R. Staskin
Training of David R. Staskin
| Cornell University | Undergraduate Degree |
| Drexel University College of Medicine | Doctorate Degree |
Statistics
International
| United States | 4 |
Operational
| Director/Board Member | 1 |
| Corporate Secretary | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | Health Technology |
- Stock Market
- Insiders
- David R. Staskin
- Experience
